GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dian Diagnostics Group Co Ltd (SZSE:300244) » Definitions » Shares Outstanding (EOP)

Dian Diagnostics Group Co (SZSE:300244) Shares Outstanding (EOP) : 625 Mil (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Dian Diagnostics Group Co Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Dian Diagnostics Group Co's shares outstanding for the quarter that ended in Sep. 2024 was 625 Mil.

Dian Diagnostics Group Co's quarterly shares outstanding declined from Jun. 2024 (627 Mil) to Sep. 2024 (625 Mil). It means Dian Diagnostics Group Co bought back shares from Jun. 2024 to Sep. 2024 .

Dian Diagnostics Group Co's annual shares outstanding stayed the same from Dec. 2022 (627 Mil) to Dec. 2023 (627 Mil).


Dian Diagnostics Group Co Shares Outstanding (EOP) Historical Data

The historical data trend for Dian Diagnostics Group Co's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dian Diagnostics Group Co Shares Outstanding (EOP) Chart

Dian Diagnostics Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 620.46 620.46 620.46 626.90 626.90

Dian Diagnostics Group Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 626.90 626.90 626.90 626.90 624.98

Competitive Comparison of Dian Diagnostics Group Co's Shares Outstanding (EOP)

For the Diagnostics & Research subindustry, Dian Diagnostics Group Co's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dian Diagnostics Group Co's Shares Outstanding (EOP) Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dian Diagnostics Group Co's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Dian Diagnostics Group Co's Shares Outstanding (EOP) falls into.



Dian Diagnostics Group Co Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Dian Diagnostics Group Co  (SZSE:300244) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Dian Diagnostics Group Co Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Dian Diagnostics Group Co's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Dian Diagnostics Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 329, Jinpeng Street, 5th Floor, Building 2, Xihu District, Zhejiang, Hangzhou, CHN, 310030
Dian Diagnostics Group Co Ltd is an independent third-party medical diagnostic service provider that provides diagnostic services outsourcing as its core business. It promotes the development of multi-service areas of medical diagnostic platforms and integrated development strategies for upstream and downstream industry chains, covering medical diagnostic services and diagnostic products.
Executives
Tao Jun Securities Affairs Representative
Chen Hai Bin Director
Chen Shi Shi Supervisors
Guo San Hui Executives
Yao Shu Lie Executives
Xu Min Director
Wang Yan Xiao Directors, executives
Chen Zuo Xiu Directors, executives
Hu Yong Director
Hu Miao Shen Executives
Chen Xue Dong Director
Jiang Tang Directors, executives
Wu Zheng Xin Executives
Cheng Xiu Li Supervisors

Dian Diagnostics Group Co Headlines

No Headlines